Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
A dose of innovation | Editorial Comment
3+ day, 10+ hour ago (110+ words) Pharma sector needs a supportive environment A top executive of Swiss pharmaceutical major Novartis, Judith Love, has underscored the importance of an ecosystem thatâs conducive to innovation in India In an interview to this newspaper this week, Ms Love…...
Why CRISPR Therapeutics Stock Rocked the Market Last Month
4+ day, 5+ hour ago (556+ words) The FDA-approved drug it helped developed saw a nearly 80% sequential rise in sales. It also booked $10 million in upfront payments with a business partner. Pioneering gene-editing company CRISPR Therapeutics(NASDAQ: CRSP) was a well-performing biotech stock in August. Its shares…...
Regulatory data protection will lift India's appeal: Novartis' Judith Love
6+ day, 2+ hour ago (105+ words) On what will make India an attractive investment destination, Love said: ''I think the number one for us to make India attractive is to create an innovative ecosystem.'' Basel-headquartered Novartis, which has the biggest research and development operation in India…...
Eli Lilly Just Announced a Major Acquisition. Here's What It Means.
1+ week, 3+ day ago (196+ words) Lilly has acquired some 26 companies since 2023. Sales of its GLP-1 drug are funding the deals. This week, Eli Lilly(NYSE: LLY) announced a deal that will add to its already formidable drug pipeline. The company's leading therapy, MER511, is in Phase…...
This New Zepbound Study Could Be Great News for Eli Lilly Investors
1+ week, 4+ day ago (281+ words) The results of a study Eli Lilly ran suggest that patients older than 55 on Zepbound incur lower healthcare costs than those not on Zepbound. This could help the company make the case for expanded Zepbound coverage. There are multiple reasons…...
Patent Cliff approaching: Can Indian pharma companies repeat past success?
1+ week, 4+ day ago (156+ words) The Economic Times Patent Cliff approaching: Can Indian pharma companies repeat past success? Indian pharma companies have evolved through several business models. Domestic branded formulations remain important for many companies. Others have built substantial API operations, generic export franchises, contract…...
Danish Krone/South African Rand (FOREX: DKKZAR) Quote
1+ week, 5+ day ago (24+ words) theglobeandmail.com Instrument NameDanish Krone/South African RandInstrument Symbol(DKKZAR) Cumulative Growth based on a $10K investment...
Intelligent Bio Solutions Issues Routine Investor Presentation Update
2+ week, 5+ hour ago (152+ words) Intelligent Bio Solutions ( (INBS) ) has provided an announcement. Spark’s Take on INBS Stock According to Spark, TipRanks’ AI Analyst, INBS is a Neutral. The score is held down primarily by weak financial performance (large losses, declining gross margin, and heavy…...
Historical Data for Merck & Co Inc (Derivatives) in USD | CryptoRank.io
2+ week, 23+ hour ago (22+ words) Historical Data for Merck & Co Inc (Derivatives) in USD CryptoRank Merck & Co Inc (Derivatives)MRK Historical Data for Merck & Co Inc (Derivatives)...
Gilead Sciences Has Snapped Out of Its Slump -- and 1 Catalyst Is Doing Most of the Heavy Lifting
2+ week, 3+ day ago (380+ words) Gilead reported big losses last quarter, but this could pave the way for its diversification into oncology. In the meantime, investors remain focused mostly on the main growth driver: HIV prevention medicines. Based on 2027 earnings forecasts, this stock may have…...